The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Evolv Technologies Holdings, Inc. | COM CL A | 30049H102 | 60,411,193 | 9,681,281 | SH | SOLE | 9,681,281 | 0 | 0 | ||
| Mind Medicine (MindMed) Inc. | COM NEW | 60255C885 | 651,272 | 100,350 | SH | SOLE | 100,350 | 0 | 0 | ||
| Recursion Pharmaceuticals, Inc. | CL A | 75629V104 | 30,062,067 | 5,941,120 | SH | SOLE | 5,941,120 | 0 | 0 | ||
| Rocket Lab Corp | COM | 773121108 | 38,740,806 | 1,083,053 | SH | SOLE | 1,083,053 | 0 | 0 | ||
| Roivant Sciences Ltd. | SHS | G76279101 | 43,671 | 3,875 | SH | SOLE | 3,875 | 0 | 0 | ||